Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 3—March 2013
Perspective

Measles Elimination Efforts and 2008–2011 Outbreak, France

Denise AntonaComments to Author , Daniel Lévy-Bruhl, Claire Baudon, François Freymuth, Mathieu Lamy, Catherine Maine, Daniel Floret, and Isabelle Parent du Chatelet
Author affiliations: Author affiliations: Institut de Veille Sanitaire, Saint-Maurice, France (D. Antona, D. Lévy-Bruhl, C. Baudon, M. Lamy, C. Maine, I. Parent du Chatelet); National Reference Centre for Measles and Respiratory Paramyxoviridae, CHU Caen, France (F. Freymuth); Université Claude Bernard Lyon 1, Lyon, France (D. Floret)

Main Article

Table

Measles-related complications among 4,968 hospitalized patients, by age group, France, January 2008–December 2011*

Complications No. (%) patients, by age group, y
p value†
<1, n = 470 1–14, n = 1,150 15–29, n = 2,290 >30, n = 1,058 Total, n = 4,968
All complications
130 (27.7)
373 (32.4)
669 (29.2)
441 (41.7)
1,613 (32.5)
<0.001
Pulmonary
Pneumonia 75 (15.9) 227 (19.7) 416 (18.2) 305 (28.8) 1,023 (20.6) <0.001
Other‡
1 (0.2)
21 (1.8)
32 (1.4)
15 (1.4)
69 (1.4)
NS
Ear, nose, throat
Otitis media 24 (5.1) 27 (2.3) 11 (0.5) 2 (0.2) 64 (1.3) <0.001
Other‡
6 (1.3)
12 (1.0)
11 (0.5)
5 (0.5)
34 (0.7)
NS
Digestive tract
Diarrhea/dehydration 3 (0.6) 26 (2.3) 30 (1.3) 19 (1.8) 78 (1.5) NS
Liver or pancreas disorder 1 (0.2) 5 (0.4) 105 (4.6) 70 (6.6) 181 (3.6) <0.001
Other‡
11 (2.3)
18 (1.6)
19 (0.8)
5 (0.5)
53 (1.1)
NS
Neurologic
Encephalitis or myelitis 0 10 (1.1) 13 (0.6) 4 (0.4) 27 (0.5) NS
Other‡
2 (0.4)
10 (0.9)
8 (0.3)
1 (0.1)
21 (0.4)
NT
Keratitis
0
1 (0.1)
9 (0.4)
6 (0.6)
16 (0.3)

Other‡ 10 (0.2) 21 (1.8) 32 (1.4) 17 (1.6) 80 (1.6) NS
Death 0 2 (0.2) 6 (0.3) 2 (0.2) 10 (0.2) NT

*Total excludes 12 patients with unknown date of birth. NS, not significant; NT, not tested (expected value <5).
†By χ2 test.
‡Other complications (numbers in brackets indicate no. cases of that complication identified): pulmonary (e.g., bronchitis, pleurisy); ear, nose, throat (e.g., tonsillitis, sinusitis); digestive tract (e.g., vomiting, dysphagia, abdominal ache); neurologic (e.g., Guillain-Barré syndrome [1], meningitis); other (e.g., miscarriage [5], premature delivery [3], neonatal infection [4], myocarditis/pericarditis [8], general state impairment [42], thrombocytopenia [18]).

Main Article

Page created: February 13, 2013
Page updated: February 13, 2013
Page reviewed: February 13, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external